HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuhiro Tsutani Selected Research

Segmental Mastectomy (Lumpectomy)

11/2022Oncological outcome of segmentectomy for early-stage non-small-cell lung cancer with invasive characteristics: a multicentre study.
11/2022Segmentectomy for Spread Through Air Spaces-positive Lung Adenocarcinoma.
1/2022Segmentectomy versus lobectomy for solid predominant cN0 lung cancer: analysis using visual evaluation of positron emission tomography.
1/2022A Multicenter Study of Complex Segmentectomy Versus Wedge Resection in Clinical Stage 0-IA Non-Small Cell Lung Cancer.
1/2022Segmentectomy versus wedge resection for radiological solid predominant and low metabolic non-small cell lung cancer.
1/2022Complex Segmentectomy for Hypermetabolic Clinical Stage IA Non-Small Cell Lung Cancer.
12/2021Postoperative Pulmonary Function After Complex Segmentectomy.
10/2021Risk of death due to other causes is lower among octogenarians with non-small cell lung cancer after wedge resection than lobectomy/segmentectomy.
10/2021Comparison of cancer control between segmentectomy and wedge resection in patients with clinical stage IA non-small cell lung cancer.
3/2021Appropriate Extent of Lymphadenectomy in Segmentectomy: A Multicenter Study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuhiro Tsutani Research Topics

Disease

40Neoplasms (Cancer)
11/2022 - 01/2006
33Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2022 - 07/2011
27Lung Neoplasms (Lung Cancer)
01/2022 - 01/2012
21Adenocarcinoma of Lung
11/2022 - 12/2012
12Adenocarcinoma
11/2022 - 05/2006
8Lymphatic Metastasis
11/2022 - 12/2012
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2021 - 07/2011
5Stomach Neoplasms (Stomach Cancer)
07/2013 - 01/2008
4Interstitial Lung Diseases (Interstitial Lung Disease)
12/2021 - 09/2019
4Margins of Excision
01/2021 - 01/2018
4Breast Neoplasms (Breast Cancer)
06/2020 - 06/2005
3Malignant Mesothelioma
02/2021 - 01/2019
2Carcinoma (Carcinomatosis)
04/2022 - 01/2007
2Lung Injury
01/2022 - 12/2021
2Disease Progression
12/2018 - 07/2017
2Neoplasm Metastasis (Metastasis)
12/2017 - 01/2008
2Esophageal Neoplasms (Esophageal Cancer)
09/2008 - 01/2007
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2007 - 03/2006
1Acute Lung Injury
01/2022
1Emphysema
07/2021
1Fibrosis (Cirrhosis)
06/2021
1Bronchial Fistula
02/2021
1Mucinous Adenocarcinoma (Mucinous Carcinoma)
01/2021
1Idiopathic Pulmonary Fibrosis
09/2020
1Anorexia
01/2020
1Esophageal Squamous Cell Carcinoma
01/2020
1Mesothelioma
03/2019
1Hypoxia (Hypoxemia)
12/2015
1Fanconi Anemia (Fanconi's Anemia)
07/2013
1Colonic Neoplasms (Colon Cancer)
07/2013

Drug/Important Bio-Agent (IBA)

10Deoxyglucose (2 Deoxy D glucose)IBA
01/2022 - 07/2011
5Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2006
5Biomarkers (Surrogate Marker)IBA
01/2021 - 03/2013
3Carcinoembryonic AntigenIBA
03/2019 - 11/2012
3Fluorouracil (Carac)FDA LinkGeneric
07/2013 - 12/2008
3Orotate PhosphoribosyltransferaseIBA
12/2008 - 01/2007
2Paclitaxel (Taxol)FDA LinkGeneric
04/2022 - 12/2008
2Bevacizumab (Avastin)FDA Link
04/2022 - 12/2018
2LigandsIBA
01/2021 - 01/2020
2Immune Checkpoint InhibitorsIBA
01/2021 - 09/2019
2NivolumabIBA
01/2021 - 01/2021
2MicroRNAs (MicroRNA)IBA
06/2020 - 01/2020
2Cisplatin (Platino)FDA LinkGeneric
01/2020 - 12/2018
2Indicators and Reagents (Reagents)IBA
01/2016 - 07/2011
2DNA (Deoxyribonucleic Acid)IBA
07/2013 - 02/2012
2Docetaxel (Taxotere)FDA Link
07/2009 - 12/2008
2Gastric MucinsIBA
05/2006 - 03/2006
2SOXB1 Transcription FactorsIBA
05/2006 - 03/2006
1ErbB Receptors (EGF Receptor)IBA
11/2022
1Carboplatin (JM8)FDA LinkGeneric
04/2022
1Receptor for Advanced Glycation End ProductsIBA
01/2022
1HMGB1 Protein (HMG1)IBA
12/2021
1Carbon MonoxideIBA
07/2021
1S100 Calcium-Binding Protein A4IBA
06/2021
1GlypicansIBA
02/2021
1xylometazoline (stas)IBA
01/2021
1Therapeutic UsesIBA
01/2021
1RNA (Ribonucleic Acid)IBA
06/2020
1Protein Isoforms (Isoforms)IBA
06/2020
1Culture MediaIBA
06/2020
1Transfer RNA (tRNA)IBA
06/2020
1liu-jun-zi-tangIBA
01/2020
1B7-H1 AntigenIBA
01/2020
1GlobulinsIBA
01/2020
1AlbuminsIBA
01/2020
1GhrelinIBA
01/2020
1Circulating MicroRNAIBA
01/2020
1Carrier Proteins (Binding Protein)IBA
10/2019
1MucinsIBA
03/2019
1Claudin-4IBA
03/2019
1Mucin-4IBA
03/2019
1AsbestosIBA
01/2019
1Pemetrexed (MTA)FDA Link
12/2018
1Biological ProductsIBA
12/2015
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
12/2015
1Keratin-19 (Keratin 19)IBA
06/2015
1Hormones (Hormone)IBA
10/2013
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
07/2013
1Oxaliplatin (Eloxatin)FDA LinkGeneric
07/2013
1Pharmaceutical PreparationsIBA
03/2013
1Antineoplastic Agents (Antineoplastics)IBA
09/2012
1ZincIBA
09/2012
1Transcription Factors (Transcription Factor)IBA
02/2012
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
02/2012

Therapy/Procedure

35Segmental Mastectomy (Lumpectomy)
11/2022 - 01/2012
12Lymph Node Excision (Lymph Node Dissection)
12/2021 - 12/2012
9Adjuvant Chemotherapy
11/2022 - 06/2005
8Operative Surgical Procedures
10/2021 - 01/2014
7Drug Therapy (Chemotherapy)
04/2022 - 01/2008
7Therapeutics
02/2021 - 01/2007
4Pneumonectomy (Lung Volume Reduction)
02/2021 - 07/2017
2Radiotherapy
03/2021 - 12/2017
2Aftercare (After-Treatment)
01/2019 - 09/2012
1Combined Modality Therapy
03/2021
1Immunotherapy
01/2021
1Induction Chemotherapy
12/2018
1Maintenance Chemotherapy
12/2018
1Neoadjuvant Therapy
07/2017
1Lasers (Laser)
02/2012
1Electrocoagulation (Electrocautery)
01/2012